Treatment for chronic myeloid leukaemia (CML)
A team of health professionals decides what treatment options you have. The main treatment for chronic myeloid leukaemia (CML) are targeted cancer drugs. These drugs are called tyrosine kinase inhibitors (TKIs).
A team of doctors and other professionals discuss the best treatment and care for you. They are the multidisciplinary team (MDT). Your MDT might include:
a blood cancer specialist called consultant haematologist
doctors specialising in reporting or biopsies. They are called haemato-pathologists
a radiologist – a doctor specialising in reporting x-rays and scans
a specialist haematology nurse – also called a clinical nurse specialist (CNS)
symptom control specialists called palliative care doctors and nurses
pharmacists
social workers
The MDT look at a number of different factors including:
the phase of your CML
whether you have other health conditions
your age, general health and level of fitness
the side effects of the different medicines
the results of tests on your CML cells
your personal situation and preference
Your doctor will talk to you about your treatment options. They will discuss the benefits and the possible side effects with you.
The aim of treatment is to put your CML into remission. Remission means there are no signs of CML in your blood. The doctors refer to remission as ‘response to treatment’.
Targeted cancer drugs are the main treatment for CML. They can change the way that cells work and help the body control the growth of cancer. There are different types of targeted cancer drugs. The main type for CML is tyrosine kinase inhibitors (TKIs).
Examples of TKI drugs for CML include:
imatinib
bosutinib
dasatinib
nilotinib
Read about targeted cancer drugs for CML
Chemotherapy and a are other possible treatments for CML. It is uncommon to have these as targeted cancer drugs work well at controlling most people's CML.
Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. The drugs circulate throughout the body in your bloodstream.
The chemotherapy drugs you have depends on the type of leukaemia your CML develops into. CML most commonly transforms into acute myeloid leukaemia (AML). So the chemotherapy treatment you have is the same chemotherapy treatment as AML.
Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-Ida) is an example of chemotherapy drug combination you might have for AML. You might also have a TKI drug alongside the chemotherapy.
Find out more about having FLAG-Ida
You might have chemotherapy if you have more advanced stages of CML or before a stem cell transplant.
Find out more about chemotherapy for CML
Having a transplant means destroying as many leukaemia cells as possible and replacing these with healthy .
You first have chemotherapy and other treatments such as radiotherapy. This prepares your body for the healthy stem cells.
After the chemotherapy you have the new stem cells into your bloodstream through a drip. These stem cells make their way to the bone marrow. Here they make the you need to recover.
You have a stem cell transplant using stem cells from someone else. This is called a donor transplant.
Read about stem cell transplants for CML
There are 3 phases (stages) of CML:
chronic phase
accelerated phase
blast phase
Most people are diagnosed in the chronic phase. The main aim of treatment is to control your CML and get you into remission. Remission means there's no sign of active leukaemia in your body. And you don’t have any symptoms. This remission can last for years.
The most common treatment is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI).
There are several different TKIs. The most common drug for CML is imatinib. But your doctor might suggest a different TKI such as dasatanib, nilotinib or asciminib.
Most people respond well to this treatment. CML can stay under control for many years.
Your doctor might suggest you try a different TKI if:
tests to look for signs of CML show that your CML hasn’t gone away
tests detect signs of CML again after a period of time
you have severe side effects from your current treatment
Occasionally TKI treatment does not work. In this situation your doctor might offer you chemotherapy and a stem cell transplant.
You might:
progress to the accelerated or blast phase after having treatment for chronic phase CML
be diagnosed in the accelerated or blast phase, although this is less common
Treatment for the accelerated or blast phase depends on whether you have already had treatment. And if so, what treatment you had.
Accelerated phase
Treatment aims to get you back into remission.
The first choice of medicine depends on several factors including if you have already had a TKI medicine.
There are several available including:
nilotinib
dasatinib
bosutinib
ponatinib
Your doctor might recommend a stem cell transplant if the TKI treatment doesn’t work. This is more likely if you:
have progressed to accelerated phase from chronic phase
are younger and fairly fit and well
Blast phase
Blast phase CML is where your CML transforms to an . The drugs you have for the blast phase CML depends on the type of leukaemia your CML develops into.
CML most commonly transforms into acute myeloid leukaemia (AML). So the treatment you have is the same treatment as AML.
The second most common transformation is acute lymphoblastic leukaemia (ALL). So if you have this type you have the same treatment as ALL.
There are other types of acute leukaemia and treatments are similar to AML and ALL. Transformation to these types of leukaemia are rarer.
Your doctor might suggest:
a combination of chemotherapy drugs such as FLAG-Ida. You have this on its own, or together with a TKI
a TKI on its own
Your doctor usually recommends you have a stem cell transplant if you are well enough and have a stem cell donor.
You might have also treatment to relieve symptoms.
You might hear your doctor refer to your treatment as first line or second line.
First line treatment
This is the first treatment you have when you are diagnosed with CML. The most common first line treatment for CML is a TKI drug.
Second and third line treatments
Some people have to change on to a different treatment. The second treatment you have is called second line treatment. And then the next treatment is called third line treatment, and so on.
The aim of second line treatment is to put your CML back into remission. Remission means there are no signs of CML in your blood.
You might have symptoms or problems caused by the leukaemia. Supportive treatments can help to either prevent or control these problems.
Some of the supportive treatments for CML include:
a chemotherapy drug called hydroxycarbamide. This is to lower your white blood cell or platelet levels. You might have this whilst you wait for your diagnosis
fluids through a drip into your vein. This is to prevent complications caused from a condition called
medicines to protect your kidneys from tumour lysis syndrome
antibiotics, antifungals and antivirals to help prevent or treat infections
Read more about the supportive treatments for CML
To begin with, you need to see your doctor regularly, maybe weekly or monthly. You usually have a blood test at each visit. Your doctor might examine you and asks you how you are. This is to see whether you have any problems with the treatment.
The time between check ups will gradually get longer if everything is going well.
The aim of treatment is to put your CML into remission. There are different tests that look for signs of CML. The test results provide information about how well the treatment is working to control your leukaemia. To monitor your response to treatment, you have blood tests every 3 to 6 months depending on your situation. You might also have bone marrow tests.
Read about monitoring treatment response
Doctors know that it is safe for some people to stop treatment if their CML is under control. This is called a treatment break. Or your doctor might call it treatment free remission.
Your doctor can talk with you about whether a treatment break might be an option for you.
Read about having a treatment break
Your doctor might ask if you’d like to take part in a clinical trial. Doctors and researchers do trials to make existing treatments better and develop new treatments.
Last reviewed: 12 Jun 2025
Next review due: 12 Jun 2028
Targeted cancer drugs called tyrosine kinase inhibitors (TKIs) are the main treatment for CML. Find out more about your treatment options, the different treatments and how they monitor treatment is working.
There are 2 systems to describe how far your CML has developed. You might have 2 or 3 phases. At the moment CML is mainly described using 3 phases. These are chronic, accelerated and blast. Knowing the phase helps your doctor decide which treatment you need.
Chronic myeloid leukaemia (CML) is often a slowly developing condition. Treatment can keep it under control for many years. Find out how to cope and what support is available.
Survival for chronic myeloid leukaemia (CML) depends on several factors including age. These figures can only give you a general guide about survival for CML.
CML starts in the white blood cells called granulocytes. It often develops slowly and treatment can keep it under control for many years. Find out more.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.